Nipple-sparing mastectomy removes breast tissue while preserving the external nipple, areola and most of the breast skin. It is usually coordinated with immediate reconstruction. Keeping the nipple can preserve a more familiar outline, but it does not turn a mastectomy into a partial operation and does not guarantee normal feeling, function or an untouched appearance.
The US National Cancer Institute explains that this approach may not be suitable when a tumour is large or close to the skin, nipple or areola, and that breast size can also affect feasibility. NCI: types of mastectomy
This guide addresses the nipple-specific decision. For the wider treatment sequence, see the clinic's breast cancer surgery pathway and guide to immediate, delayed and staged reconstruction.
What is preserved—and what is not?
The visible nipple–areola complex and the skin envelope are preserved. The breast tissue underneath is removed as part of the mastectomy, including tissue directly behind the nipple. The operating and pathology teams assess a separate nipple or retroareolar margin according to the agreed protocol.
The international Oncoplastic Breast Consortium reached strong consensus that clinical evidence of nipple involvement or cancer at the nipple margin is a reason not to preserve the nipple. If the final pathology is positive, additional surgery may be advised even when the nipple looked healthy during the operation. The exact response is individual and should be discussed by the multidisciplinary team. International nipple-sparing mastectomy consensus
Preserving appearance is not the same as preserving nerves or blood supply. The nipple can become flatter, change position or colour, lose projection, lose sensation, or occasionally require later removal if its circulation fails or pathology shows cancer.
Who may be considered for nipple-sparing mastectomy?
It may be considered for selected people having mastectomy for ductal carcinoma in situ, invasive breast cancer, or risk reduction because of a very high inherited risk. The key word is selected: the indication for mastectomy must first be sound, and examination and imaging should not suggest involvement of the nipple or overlying skin.
The decision is not made from one tumour-size or tumour-to-nipple-distance number alone. The team considers the diagnosis, tumour location and extent, nipple symptoms, imaging, breast size and shape, skin quality, previous scars or radiotherapy, smoking, general health, the likely need for radiotherapy and the reconstructive plan. A larger or drooping breast may need a different incision, a staged reshaping procedure or another mastectomy approach; it is not an automatic yes or no.
Before consenting, ask the team to compare breast-conserving surgery when oncologically appropriate, conventional or skin-sparing mastectomy, nipple-sparing mastectomy, reconstruction options and an aesthetic flat closure. Nipple preservation should never be used to pressure someone into reconstruction.
What does the cancer-safety evidence show?
The evidence is reassuring for appropriately selected patients, but it is mostly observational rather than randomized. A large single-centre cohort reported 2,182 nipple-sparing procedures; among the earlier cancer cases with longer follow-up, recurrence rates were low and no recurrence occurred in the retained nipple–areola complex across the whole cohort. The study only included patients without clinical or imaging evidence of nipple involvement, so its results should not be generalized to every tumour. Smith and colleagues, JACS cohort
A 2026 systematic review and meta-analysis included 60 studies and 7,752 patients. It found long-term survival and recurrence outcomes comparable with skin-sparing or modified radical mastectomy, with little nipple–areola recurrence in appropriately selected patients. Selection differences and the non-randomized evidence base remain important limitations. 2026 updated systematic review and meta-analysis
Nipple-sparing surgery does not decide whether lymph-node surgery, chemotherapy, endocrine therapy, targeted therapy or radiotherapy is needed. Those decisions depend on the diagnosis, stage, biology and final pathology. If sentinel-node biopsy is being discussed, the patient guide to sentinel lymph-node biopsy explains that separate decision.
Will the nipple still have normal sensation?
Often not. The nerves that supply the breast skin and nipple can be divided or stretched when the breast tissue is removed. In a prospective study that tested sensation before surgery and again at one year, both nipple-sparing and skin-sparing groups had a substantial reduction in skin sensation; nipple–areola sensation was retained only in a subset of the nipple-sparing group. Dossett and colleagues, prospective sensation study
Some people notice partial sensation, tingling or altered sensitivity over time, while others remain numb. Erotic sensation and nipple response cannot be promised. Reduced sensation also means that heat, ice, pressure or friction may injure the skin without an early warning from pain, so follow the protection instructions from your own surgical team.
How is the nipple's blood supply protected?
After breast tissue is removed, the nipple and skin rely on the remaining skin blood supply. Incision choice, flap handling, breast anatomy and surgical experience can affect the risk of poor circulation and tissue loss. The team may alter the incision, stage a breast reduction or lift, change the reconstruction, or decide during surgery that preservation is unsafe.
Mild bruising can occur, but a new or worsening pale, dusky, blue, grey or black colour, cool skin, blistering, rapidly increasing swelling or severe pressure pain needs direct assessment by the operating team. Do not wait for a routine appointment and do not apply heat, ice, pressure or creams unless your team specifically instructs you.
General mastectomy complications include bleeding, fluid collection, infection, blood clots, shoulder stiffness, altered sensation and lymphoedema. The NHS advises urgent help after mastectomy for sudden pain or swelling or wound bleeding, and emergency care for severe breathing difficulty, chest or upper-back pain, a very fast heartbeat or collapse. NHS mastectomy recovery and urgent advice
The safety panel below separates same-day surgical review from emergency symptoms. The clinic's wound-healing guide gives additional practical context, but it cannot replace inspection of a threatened nipple or skin flap.
Questions to settle before surgery
Ask why mastectomy is recommended and whether breast-conserving treatment is a safe alternative.
Ask what the examination and imaging show about the nipple, skin and distance from the tumour, and whether any nipple symptom changes the plan.
Ask how the nipple margin will be assessed, when the final result will be available and what the team would recommend if it contains cancer.
Ask which reconstruction or flat-closure options are suitable, how possible radiotherapy changes the choice, and whether more than one operation is likely.
Ask about the realistic chance of nipple or skin loss, altered sensation, asymmetry and revision surgery in your specific anatomy and health context.
Ask who checks the nipple after discharge, how to send a photograph without delaying care, which hospital can examine you urgently and what 24-hour number to use.
Choosing a surgical team objectively
If you searched for “best breast surgeon in Cairo”, use the clinic's objective surgeon-selection checklist rather than a ranking: verify professional registration and breast-specific training, relevant nipple-sparing experience, coordinated breast-radiology, pathology and reconstructive input, a clear circulation-monitoring pathway, and a documented plan for a positive nipple margin. These are objective questions; they do not establish that any individual is universally or objectively best.
Evidence, medical review and scope
The six references linked in this article and repeated in the safety panel were checked on 1 October 2026. The evidence supports nipple-sparing mastectomy for appropriately selected patients, but it cannot determine your eligibility or predict your result.
This article is for general education only. It is not personal medical advice, a diagnosis or consent for surgery. Your breast surgeon, reconstructive surgeon, radiologist, pathologist and oncology team must use your examination, imaging, biopsy, cancer treatment plan, health and preferences to recommend an individual approach.
